Michael Mandel

Michael Mandel has worked in various roles in the investment banking and business development industries since 1990. Michael began their career at Hyland Turnkey as a Project Manager and Director of Finance, then moved to Paine Webber as an Associate of Healthcare Investment Banking in 1996. In 1999, they were promoted to Vice President of Healthcare Investment Banking at Banc of America Securities. In 2005, they joined BMO Capital Markets as a Director of Healthcare Investment Banking. In 2012, they were appointed Managing Director, Head of Healthcare Investment Banking at Landmark Ventures. In 2014, they moved to Brean Capital, LLC as a Managing Director of Healthcare Investment Banking. In 2021, they were appointed Head of Corporate Development at Advanced NanoTherapies, Inc. Most recently, in 2022, they joined T45 Labs as Partner and Chief Business Development Officer.

Michael Mandel received their MBA from Columbia Business School in 1996, after graduating with a Bachelor of Commerce from the University of Manitoba in 1989. Their field of study for both degrees was Finance.